2 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 3 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow RestoreX: new trials by email Literature Review of RestoreX trials Research Report on RestoreX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Penile Lengthening Pre-Penile Prosthesis Implantation Penile Traction Device, Inflatable Penile Prosthesis Implantation - Erectile Dysfunction | Not applicable | Recruiting | J. Peter Rubin, MD | 48 | 2025-08-26 | 2026-09-03 |
| Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease Collagenase Clostridium Histolyticum, RestoreX, Sildenafil - Peyronie Disease | Phase 4 | Active not recruiting | Charitable Union for the Research and Education of Peyronie's Disease | 40 | 2024-10-11 | 2026-08-26 |
| Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders CCH administration, Control - Crossover to CCH, RestoreX - Peyronie's Disease | Phase 4 | Completed | Charitable Union for the Research and Education of Peyronie's Disease | 40 | 2021-09-20 | 2026-08-26 |
| Penile Lengthening Pre-Penile Prosthesis Implantation RestoreX, Control - Erectile Dysfunction | Not applicable | Terminated | Mayo Clinic | 24 | 2018-03-23 | 2020-01-06 |
| Penile Length Maintenance Post-Prostatectomy RestoreX, No treatment - Prostate Cancer, Penile Diseases | Not applicable | Completed | Mayo Clinic | 82 | 2018-03-23 | 2021-10-20 |
Erectile Dysfunction (2) · Penile Induration (2) · Penile Diseases (1) · Prostatic Neoplasms (1)
Charitable Union for the Research and Education of Peyronie's Disease (2) · Mayo Clinic (2) · J. Peter Rubin, MD (1)
United States (5)
Landon Trost, MD (2) · J. Peter Rubin, MD (1) · Landon W Trost (1) · Matthew Ziegelmann, MD (1)